REPEL-CV

FDA Premarket Approval P070005 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval of the post-approval study protocol.

DeviceREPEL-CV
Generic NameBarrier, Adhesion, Cardiovascular
ApplicantPATHFINDER CELL THERAPY INC.
Date Received2011-03-07
Decision Date2011-05-05
PMAP070005
SupplementS002
Product CodeOBD 
Advisory CommitteeCardiovascular
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonPostapproval Study Protocol - Osb
Expedited ReviewNo
Combination Product No
Applicant Address PATHFINDER CELL THERAPY INC. 12 Bow Street cambridge, MA 02138

Supplemental Filings

Supplement NumberDateSupplement Type
P070005Original Filing
S002 2011-03-07 Normal 180 Day Track No User Fee
S001

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.